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Abstract. Micromethods for estimation of bilirubin uridine diphos-
phate-g1ucurony1 and -xy1osy1 transferases in liver are described. With
these methods, a liver specimen as small as 10 mg is sufficient for assay
of either enzyme activity and 15 mg is sufficient for assay of both
enzymes. Normal values for livers with minimal elevation of SGOT
and minimal histological change were 0.260-0.400 Dig protein for glucu-
ronyl transferase and 0.142-0.302 Dig protein for xylosy1 transferase.
Key words: bilirubin-DDP-g1ucurony1 transferase, bilirubin-xylosyl
transferase, human liver, liver biopsy
Post-obstructive bile and normal bile of humans (1,2) and rats (3) contain
bile pigments of complex composition (4-6). The dominant components are
bilirubin glucuronides and other components include bilirubin xylosides and
bilirubin glucosides (1, 7).
Various methods for determination of the activity of bilirubin uridine
diphosphate-glucuronyl transferase (BUDP-GT) have been reported by Grodsky
and Carbone (8), and Black et ai. (9). Their procedures, however, require more
than 20 mg of liver specimen for one assay. Although the assay of glucuronyl
transferase activity using other substrates such as 4-methylumbelliferone (10),
p-nitrophenol (11) or 14C-p-nitrophenol (12) required less material, the results
were inconsistent with those obtained when bilirubin was the substrate (13, 14).
In 1972, Fevery et ai. (15) described a method for determining bilirubin
uridine diphosphate-xylosyl transferase (BUDP-XT) in rat liver and estimated
the activity in human liver as 30/73 that of rat liver (16). These two enzymes
are assumed to be separate proteins at present. Since only 30 to 50 mg of speci-
men can be obtained by one liver biopsy, a micromethod by which the BUDP-GT
and - XT activities together with the protein concentration of liver homogenate
could be measured is necessary. This report introduces such methods.
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MATERIALS AND METHODS
Chemicals. Bilirubin was obtained from Daiichi Kagaku Co. Ltd. Tokyo and
used without further purification. Bovine serum albumin (BSA) obtained from
Sigma Chemical Co. (U. S. A.) was dissolved in distilled water and adjusted to pH
7.4 with O.lN NaOH. Uridine diphosphate glucuronic acid (UDP-GA) and uridine
diphosphate xylose (UDP-X) were obtained from Sigma Chemical Co. All other
chemicals used were of reagent grade.
Biological materials. For the study of assay methods of BUDP-GT and
BUDP-XT, a liver obtained from a patient with heart disease 12 h after sudden
death was used. It was cut into pieces each of approximately 100 mg of wet
weight, then washed with ice cold O.l5M KCl and stored at - 70<)C until used.
For determination of the enzyme activities, liver specimens (15-30 mg) were
obtained during laparoscopy, washed, kept ice cold and assayed within 2 h. The
liver was homogenized in 10 volumes (150-300/11) of O.l5M KCl containing 1%
digitonin in a small teflon-glass homogenizer under ice cold conditions. The pro-
tein concentration of the homogenate was determined by the method of Lowry
et al. (17).
Assays for BUDP-GT and -XT activities. The procedures of Gartner and
Arias (18) and Black et al. (9) were modified as follows. Before the enzymatic
incubation, homogenates were preincubated at O°C for 30 min. A small portion
of the homogenate was spared for protein determination. The presence of digi-
tonin in the homogenate did not affect this reaction. The standard assay system
consisted of 15 pI of O.l2M triethanolamine-HCl buffer, pH 6.70; 5 pI of 0.3M
MgClz ; 50 pI of distilled water; 10 pI of 60 mM UDP-GA or 10 pI of 74.6 mM
UDP-X; 50 pI of 0.68 mM bilirubin in 5% BSA solution, pH 7.4. The reaction
was started by adding 50,al of liver homogenate in digitonin solution (approxi-
mately 5 mg of wet weight) and proceeded in darkness at 37°C for 40 min under
shaking. At the end of incubation the reaction tubes were placed in an ice-water
bath and l80,al of McIlvains' buffer (19) (0.96 M citric acid and 0.04 M dibasic
sodium phosphate, pH 2.2) were added. Total and direct-reacting bilirubin con-
centrations were measured by a modified method of Hargreaves (20) as follows.
A control reaction were performed in the same system except for the absence of
UDP-glycosides. Enzyme activities were expressed as international units.
Bilirubin measurement. Hargreaves' method (20) was employed. Total biliru-
bin: 450 pI of 995% ethanol were added to 150 pI portion of the reaction mixture
described above and mixed well. Then 50 pI of Ehrlich's diazo reagent and 10 pI of
saturated ammonium sulfate solution were added in succession. The contents
were mixed by inversion and allowed to stand at -12°C for at least 30 min, then
centrifuged at 2,000 x g for 10 min. The absorbance of the supernatant thus ob-
tained was determined at 525 nm in a glass microcell with a 10 mm light path.
Direct bilirubin; 50 pI of Ehrlich's diazo reagent was added to 150 pI portion of
the reaction mixture. This was kept at room temperature for 30 min, 10 pI of 5%
ascorbic acid solution added, and the solution allowed to stand for 5 min. Then,
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10 pI of saturated ammonium sulfate solution and 450 ,ILl of ethanol were added,
the solution was mixed well by inversion, kept at -12°C for at least 30 min, then
centrifuged at 2,000 x g for 10 min. Absorbance of the supernatant was measured
at 525nm.
RESULTS
Preincubation of the homogenate with digitonin gave higher activities for
BUDP-GT and -XT. The results were 209% and 213% greater than those
obtained without digitonin.
Effects of several factors were examined on both the BUDP-GT and -XT
catalyzed reactions. Between 0 and 0.78 mg of homogenate protein (about 0-
7.5 mg of the liver wet weight) in the standard assay systems the formation of
direct bilirubin increased linearly as the molar ratio of bilirubin to albumin was
kept at 0.92 (Fig. 1), the reaction rate increased and reached plateau with in-
creasing bilirubin concentration up to 0.19 mM (Fig. 2). The rates of both the
reactions increased as UDP-GA and UDP-X concentration increased and reached
plateaus at QmM and 2.5 mM respectively. Both the reactions showed bell-
shaped pH responeses with maxima at pH 6.70. In the standard assay systems
the transfer rates of both UDP-sugars increased almost linearly with the increase
of reaction time up to 60 min. Both enzymes were slightly activated by Mg++.
Their activities were maximal at 9 mM MgClz in the assay solutions. The
normal value of BUDP-GT activity using livers of 3 control subjects with
minimal elevation of SGOT and minimal histological change was 0.260-0.400
A. BUDP-GT
Homogenate added to assay
(mg of protein)
0.8
B. BUDP-XT
0.2 0.4 0.6 0.8
Homogenate added to assay
(mg of protein)
Fig. 1. Effect of enzyme concentration on bilirubin-glycoside formation. In the standard
assay solution, between 0.1 and 0.8 mg of homogenised protein were examined. With boiled
liver homogenate no bilirubin conjugation was observed. The procedure is described in the
text.
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Fig. 2. Effect of bilirubin concentration on bilirubin-glycoside formation. Approximately
0.5 mg of homogenate protein was used in the experiments. Addition of 0.19 mM of bilirubin
to the reaction mixture resulted in a plateau of enzyme activity. The procedure is described
in the text.
and that of BUDP-XT activity was 0.142-0.302 U/g protein. The value for the
coefficient of variation obtained by duplicate assays was less than 4.5 %.
DISCUSSION
Since the discovery of steroid glucosides, bilirubin glucoside and bilirubin
xyloside (21), the presence ofUDP-glycosyl transferases which catalyze the for-
mation of these glycoside has been demonstrated in rat, mouse and rabbit livers
(15,22). In general, glucuronide formation is the dominant pathway in bilirubin
metabolism in mammals, and glucuronyl transferase activities in a variety of
liver diseases using different substrates are under investigation. The differences
between BUDP-GT and phenol-UDP-GT activities observed in Crigler-Najjar's
syndrome (14) and Gilberts syndrome (13) may be ascribed to the difference in
substrates used. In livers of 4 Crigler-Najjar children, 17 patients with Gilbert's
syndrome, and in chronic alcoholism, BUDP-GT activity was zero or markedly
decreased, whereas activities for p-nitrophenol and 4-methylumbelliferone used
as sugar acceptors were subnormal or increased (14, 24, 25). Whether these two
activities are ascribed to an identical enzyme or not is poorly understood at pre-
sent, particularly in man, therefore, BUDP-GT activity should be determined
in these diseases, especially for constitutive jaundice. Technical difficulties in
the in vitro procedure were encountered in using the method in which bilirubin
was replaced by aglycones such as 4-methylumbelliferone (10) and p-nitrophenol
(12) in the incubation system. The procedure introduced by Metge et ai. (26) and
Menken et ai. (27) employing radioactive materials needs a special instrument.
The present study was undertaken to apply the methods of Gartner and
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Arias (18) and Black et al. (9) to the determination of BUDP-GT and -XT activ-
ities in liver biopsy specimens, and to establish a procedure by which accurate
estimation of small quantities of conjugated bilirubin could be achieved in the
presence of an excess of unconjugated bilirubin.
Activation of microsomal enzymes by detergents such as digitonin is not
completely understood. Winsnes (28) has recently investigated this using several
of the hepatic glucuronyl transferases. He concluded that "unmasking of an
active site" occurred.
Fevery et at. (21) reported that BUDP-GT and -XT activities in rat liver
increased l4-fold and 2.5-fold respectively following pretreatment with digitonin.
Black et al. (9) reported that BUDP-GT actitivity in the human liver was in-
creased 4-fold. Our experiment showed that BUDP-GT and BUDP-XT activities
increased 2-fold. The differences in activation ratios was thought to depend, in
part, on species differences.
Fevery et at. (21) reported that the pH optima for BUDP-GT and -XT
activities in the rat was pH 7.96 and pH 6.6-7.2 respectively. Our experiment
showed that the optimum pH for both enzymes in human liver was pH 6.70.
The difference may be related to differences in preparation of liver homogenates
and conditions of the reaction.
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